This e-newsletter is sponsored by
|
|
Contact Us | |
American Society of
Bariatric Physicians
2821 S. Parker Road
Ste. 625
Aurora, CO 80014
303.770.2526 | asbp.org
Staff
Laurie Traetow, CAE
Executive Director
laurie@asbp.org
Beth Amelon
Administrative Coordinator
beth@asbp.org
Carly Crosby
Administrative Coordinator
carly@asbp.org
Peter Conway
Intern, Marketing & Communications
peter@asbp.org
Heidi Gordon
Director of Marketing &
Communications
heidi@asbp.org
|
|
|
|
Obesity Medicine e-Weekly
|
News
Vivus announces initial availability of Qsymia through certified retail pharmacies
 Yesterday, Vivus, Inc., announced initial availability of its prescription-only weight management medication, Qsymia (phentermine and topiramate extended-release) capsules CIV in thousands of certified retail pharmacies, ahead of the previously-stated mid-July 2013 schedule. As of July 1, Qsymia is available in approximately 8,000 Walgreens, Costco and Duane Reade retail pharmacies nationwide. VIVUS will continue to certify and add to the Qsymia retail pharmacy network, including well-known national and regional chains as well as independent pharmacies, in the coming weeks and months. Click here to read the complete news release from Vivus, Inc.
Reminder: ASBP member badge now available to you to identify your affiliation with the Society
The Society is pleased to announce a new member benefit: use of the ASBP member-of badge. Now, you may display your affiliation with the Society on marketing collateral, stationery and digital marketing materials! Current members of the Society may click here to be redirected to a log-in web page with terms of usage and download instructions.
First submission deadline for abstracts is Aug. 16
 The Society is pleased to announce its 2013 call for abstract submissions of clinical research in obesity medicine is now open. The Society is accepting abstracts for presentation and/or posters during the 63rd Annual Obesity & Associated Conditions Symposium, Overcoming Obesity: Diagnose. Personalize. Treat., which is Oct. 9-13 at the Arizona Biltmore in Phoenix. Abstract submission schedule:
- Aug. 16 - Early Submission Closes
- Aug. 20 - Notification of Acceptance Begins
- Aug. 30 - Late Submission Closes
Click here to download ASBP Abstract Submission Guidelines. Click here to submit your abstract using the new online form. Questions? Please click here to send an e-mail to ASBP Health Director Stacy Schmidt, Ph.D.
National parks dishing up healthier fare this summer
 If you take a vacation at a national park this summer, you may expect it to be a healthy one with fresh air, hiking and the great outdoors. Now, though, you also will find healthier food and beverage options with the Healthy and Sustainable Food Program. Click here to read a story from USA Today.
|
|
Resources
Obesity Updates: Click titles to view articles
Bhat, S.L., et al. Metabolism: Clinical and Experimental. June 2013.
Elevated plasma glucose concentration is often used to identify individuals at increased risk of type 2 diabetes and coronary heart disease (CHD). However, postprandial glucose may be a better predictor of risk. The quantification of postprandial glucose concentrations has relied on measurement of the plasma glucose response to a 75 g oral glucose challenge, which does not necessarily represent response to ingestion of mixed meals. This study aimed to evaluate the association between conventional CHD risk factors and fasting plasma glucose (FPG), daylong glucose and insulin responses to mixed-meals, and insulin resistance in a large population of individuals without diabetes. Researchers found that higher FPG concentrations was correlated with higher daylong incremental insulin responses to meals, and greater degrees of insulin resistance were associated with worse CHD risk profile (higher blood pressures, higher triglycerides and lower high density lipoprotein cholesterol concentrations). Interventional efforts aimed at decreasing CHD in such individuals should take these abnormalities into consideration.
Au, N., et al. Nutrition & Diabetes, June 2013.
It is well known that people's actual behavior departs significantly from their intended behavior. Studies have shown that pre-commitment (or commitment) mechanisms may assist individuals who have difficulty sticking to a healthy eating plan by removing future temptations to deviate from the plan. That is, they could be used to protect long-term health goals from short-term consumption decisions. Preselecting the list of food items to buy at the supermarket are examples of strategies to constrain oneself from giving in to future unhealthy temptations. This study analyzed whether pre-commitment interventions that facilitate healthier diets are a cost-effective approach to tackle obesity. The findings suggest grocery shopping to a predetermined list combined with standard behavior therapy is a cost-effective means for reducing obesity and its related health conditions.
Yassin, A. A., and Doros, G. Clinical Obesity, June 2013.
Low testosterone (T) is associated with increased fat mass and reduced muscle mass, which contributes to obesity and health risks, such as cardiovascular disease. Short-term T treatment of hypogonadal men improves muscle mass and reduces fat mass; however, the long-term effects of T on body composition are not known. Hypogonadal men (n=261) received parenteral T undecanoate 1000 mg every 12 weeks after an initial interval of six weeks for up to five years. T treatment produced significant, gradual and sustainable weight loss and this was associated with marked reductions in waist circumference and body mass index. These data suggest that in hypogonadal men, T therapy may increase lean body mass and decrease fat mass
|
ASBP member serves as Indiana General Assembly Physician of the Day
 | | Dr. Chamberlin-Snyder |
Dr. Erin Chamberlin-Snyder (Anderson, Ind.) recently notified the Society about her experience serving as the Physician of the Day for the Indiana State General Assembly. The Indiana Academy of Family Physicians and the Indiana State Medical Association sponsor the Physician of the Day program, which allows physicians to observe the legislative process firsthand and meet with their state legislators. Indiana Senate Resolution 107 recognizes Dr. Chamberlin-Snyder for her service. Click here to read the resolution.
|
|
Education
Attend the Obesity Basic Medical Treatment course on July 13 in Virginia Beach
 The next of the summer Obesity Basic Medical Treatment courses is Saturday, July 13, in Virginia Beach, Va. Attendees earn 7 hours of continuing medical education (CME), plus the second and subsequent registrations from the same office receive a $30 discount. The registration fee is $199, if received by the Wednesday prior to the course or $225 from Thursday to Saturday. The course, presented by the Obesity Medicine Association (a division of the Society), provides basic clinical information and tools to effectively treat patients affected by obesity and related conditions. Click here to learn more, or download a registration form and read details about the course. Online registration is also available for the course on Saturday, Aug. 3, in Providence, R.I.
Overcoming Obesity: Diagnose. Personalize. Treat.
ASBP 63rd Annual Obesity & Associated Conditions Symposium offers up to 30 CME Hours
|
|
|
|
|
